发明授权
EP0049842B1 Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates 失效
替代的苯酚衍生物衍生物,用于制备和用于治疗包含其中的高血压的药物组合物的方法和中间体

  • 专利标题: Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates
  • 专利标题(中): 替代的苯酚衍生物衍生物,用于制备和用于治疗包含其中的高血压的药物组合物的方法和中间体
  • 申请号: EP81107932.6
    申请日: 1981-10-05
  • 公开(公告)号: EP0049842B1
    公开(公告)日: 1985-08-28
  • 发明人: Harris, Elbert E.Taub, DavidThorsett, Eugene D.
  • 申请人: Merck & Co., Inc.
  • 申请人地址: 126, East Lincoln Avenue P.O. Box 2000 Rahway New Jersey 07065-0900 US
  • 专利权人: Merck & Co., Inc.
  • 当前专利权人: Merck & Co., Inc.
  • 当前专利权人地址: 126, East Lincoln Avenue P.O. Box 2000 Rahway New Jersey 07065-0900 US
  • 代理机构: Abitz, Walter, Dr.-Ing.
  • 优先权: US194691 19801006; US299051 19810904
  • 主分类号: C07D225/02
  • IPC分类号: C07D225/02 A61K31/395
Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates
信息查询
0/0